Skip to main content
Real-world study compares discontinuation rates of tofacitinib and TNFi in RA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Real-world study compares discontinuation rates of tofacitinib and TNFi in RA
User login
Username
Password
Reset your password
Concept
Lead
score
Rheumatoid Arthritis
1
1
Interstitial Lung Disease
0
1
Lung
0
0.71
Arthritis
0
0.47
Specialty
Lead
score
Rheumatology
1
1
Internal Medicine
0
1
Orthopaedics
0
0.84
Pulmonary Medicine
0
1
Edit Tags